Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.
about
Chemotherapy wafers for high grade gliomaMalignant gliomas: old and new systemic treatment approachesGliomas: Survival, origin and early detection.Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.Intraoperative magnetic resonance imaging with the magnetom open scanner: concepts, neurosurgical indications, and procedures: a preliminary report.Intra-operative MRI (iop-MR) for brain tumour surgery.A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosisMulti-modal glioblastoma segmentation: man versus machine.Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice.Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.Deconvolution of the gene expression profiles of valuable banked blood specimens for studying the prognostic values of altered peripheral immune cell proportions in cancer patientsBiopsy versus resection for malignant glioma.A Bioengineered Peptide that Localizes to and Illuminates Medulloblastoma: A New Tool with Potential for Fluorescence-Guided Surgical ResectionTemozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.Brain tumors in the older person.Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004.Down-modulation of Bis reduces the invasive ability of glioma cells induced by TPA, through NF-κB mediated activation of MMP-9Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas.Fluorescent affibody peptide penetration in glioma margin is superior to full antibodyPatients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors?Methyl gallate isolated from Spondias pinnata exhibits anticancer activity against human glioblastoma by induction of apoptosis and sustained extracellular signal-regulated kinase 1/2 activation.Brain tumours in Sweden 1996: care and costs.High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI.Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgerySerial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant gliomaNimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumabThe level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implicationsThe prognostic influence of bcl-2 in malignant gliomaOMICS and brain tumour biomarkers.Outcome of patients with glioblastoma in Saudi Arabia: Single center experience.Applications of emerging molecular technologies in glioblastoma multiformeLanguage mapping with navigated repetitive TMS: proof of technique and validation.Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma.Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.Adult gliosarcoma: epidemiology, natural history, and factors associated with outcomeHandheld confocal laser endomicroscopic imaging utilizing tumor-specific fluorescent labeling to identify experimental glioma cells in vivo.Anaplastic oligodendroglioma.
P2860
Q24235641-3A39243C-0BAE-4AF4-A80C-BA8759D2D407Q26744387-7E2C8E10-47FF-4422-8F0F-26A56BAE1A6FQ30477563-221D0BC6-E3B3-4057-9500-FA57DB4A4F3FQ30585474-942EFA0C-847C-41CD-8AA5-912ADAE8523CQ32002130-D88BA238-0134-4B18-8CBE-A8E8EF173956Q33411344-AF7F2864-03CC-4B59-99E2-1381161360F5Q33573296-9FE78F3B-3CDE-4029-9772-BFACAB8E9FE6Q33574567-137357D4-3B92-4E7F-812D-7D3FF7256BD7Q33578182-CDE3357E-BAF2-4AF2-82B3-251C5919BB4FQ33599200-E5836554-551C-493C-87B3-C0BC3BAC8481Q33604236-DA9C69E7-3A6D-48DF-901F-53FBE188C444Q33779136-84614C0C-4FD8-4335-8993-BBFD28F3DBBFQ33800793-E66731BC-B7E8-46C4-B820-4A07877ED085Q33910051-D7F3669F-E137-4DFC-8265-60C4E7AFBFA4Q33914493-D743FCAE-DEEA-4A93-BE97-96661AC6E935Q33973844-B502453D-A975-4E51-ADD0-A226452FB0ABQ34087862-C9BB0EA7-370E-400D-9DEA-0631AC93E7A2Q34132971-932D4056-B8A0-4680-9BE3-395B4F17C4B0Q34179905-51C4852E-2A55-4BA8-9873-19113B947E1FQ34369456-9C98BC27-535F-4CCC-BD48-345EF1980051Q34673086-E3D4D49C-D738-43C8-831C-E02F6123D669Q34769937-D8D9F14D-7FFC-4BCC-98CE-2FF29C6C2E52Q35038271-A6307101-5346-4E97-8AAA-FBF7478D2306Q35228593-72039B18-35AA-407D-AB49-23987E61DD47Q35459947-6C0B6C41-9D0B-4693-A3BB-A4F096CE98B0Q35625666-12CDC68E-1A5F-4888-9163-CFFA9983281CQ35914767-371D40EE-0715-4489-927A-CBC3FDC69971Q36021392-133537FA-206B-4CCB-BA3F-179609E12B20Q36285551-B339F0CF-2FD1-4C44-A018-85C69105959DQ36622637-C544D5F4-EA5B-4089-93C3-13CAB46CB5C6Q36644672-66D1AC03-3F2D-4732-95D2-694755C175C1Q36665688-52CFACE4-B1B5-48EA-A641-E559C71900CDQ36824674-A2CBAD2E-54BC-44DC-B1E2-9249EE19FEA0Q36965370-FFC4A64E-5458-470D-8827-B384D81FC6D6Q37138365-1D88F4F7-DD44-402E-95AE-012582BFB611Q37157248-FEA07B09-768B-483F-B1F8-A8E9F2A6E128Q37160479-03BD64EB-5816-4F2B-8FDB-EF571C75C3EBQ37284316-8FE21FCE-8712-4D63-BA7F-0067F43C4848Q37585126-E8998AEA-EB1F-46E1-B706-2E62164B7714Q37714906-81EEE5E9-1971-41EC-8A3A-04A667B893AC
P2860
Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Resection, biopsy, and surviva ...... ameters, therapy, and outcome.
@en
Resection, biopsy, and surviva ...... ameters, therapy, and outcome.
@nl
type
label
Resection, biopsy, and surviva ...... ameters, therapy, and outcome.
@en
Resection, biopsy, and surviva ...... ameters, therapy, and outcome.
@nl
prefLabel
Resection, biopsy, and surviva ...... ameters, therapy, and outcome.
@en
Resection, biopsy, and surviva ...... ameters, therapy, and outcome.
@nl
P2093
P1476
Resection, biopsy, and surviva ...... ameters, therapy, and outcome.
@en
P2093
P304
P356
10.3171/JNS.1993.78.5.0767
P407
P577
1993-05-01T00:00:00Z